Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early LMWH in Traumatic Brain Injury
NCT00170378Phase 4Completed
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Dec 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of enoxaparin in venous thromboembolism (VTE), sponsored by Hennepin Healthcare Research Institute. Primary endpoint: Exacerbation of Intracranial Hemorrhage. Started Dec 2002; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00170378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170378.